record state
frontier-ownedReview status
This finding is part of accepted frontier state. Review events, reviewable changes, and proof state explain how it can change.
unreviewed
frontiers / frontier
Finding bundle
back to stateno incoming links yet
record state
frontier-ownedThis finding is part of accepted frontier state. Review events, reviewable changes, and proof state explain how it can change.
finding statement
finding typeNo entity list is declared.
evidence
source-boundexperimental · manual state transition; placebo-controlled clinical trial where source reports control arm · Homo sapiens
proof impact
packet context1 reviewable changes and 0 evaluation records are attached to this finding id.
Evidence and conditions
method
manual state transition; placebo-controlled clinical trial where source reports control arm
evidence type
experimental
species
Homo sapiens
evidence spans
TRAILBLAZER-ALZ Phase II (NCT03367403): Significant slowing of iADRS decline (−6.86 vs −10.06); rapid and near-complete amyloid clearance confirmed.
TRAILBLAZER-ALZ Phase II (NCT03367403, Eli Lilly, Phase II): Established proof-of-concept for donanemab and introduced tau-based patient stratification. · curator_source · 10.1056/NEJMoa2105073
conditions
Provenance
source title
TRAILBLAZER-ALZ Phase II (NCT03367403, Eli Lilly, Phase II): Established proof-of-concept for donanemab and introduced tau-based patient stratification.
doi
10.1056/NEJMoa2105073
authors
reviewer:will-blair-bot
TRAILBLAZER-ALZ Phase II (NCT03367403): Significant slowing of iADRS decline (−6.86 vs −10.06); rapid and near-complete amyloid clearance confirmed.
vs_389ee6e7b8c090d0 · source:TRAILBLAZER-ALZ Phase II (NCT03367403, Eli Lilly, Phase II): Established proof-of-concept for donanemab and introduced tau-based patient stratification.|section:curator_source · manual_curation
outgoing
No outgoing links.
incoming
No incoming links.
events
vev_378b41e77457943bfinding.assertedManual finding added to frontier state
reviewer:will-blair-bot · 2026-05-06
reviewable changes
vpr_396b5b07382da500finding.addManual finding added to frontier state
applied · reviewer:will-blair-bot · 2026-05-06
evaluations
No evaluation record targets this finding id.